{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T18:48:46Z","timestamp":1786387726593,"version":"build-2736575974"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Center for the Science of Health Care Delivery"},{"name":"Mayo Clinic Clinician Investigator Training program"},{"name":"Clinician Investigator Training Program"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Surgery"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.ijsu.2018.02.052","type":"journal-article","created":{"date-parts":[[2018,2,26]],"date-time":"2018-02-26T18:29:12Z","timestamp":1519669752000},"page":"171-179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Adjuvant systemic therapy after resection of node positive gallbladder cancer: Time for a well-designed trial? (Results of a US-national retrospective cohort study)"],"prefix":"10.1097","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4142-4905","authenticated-orcid":false,"given":"John R.","family":"Bergquist","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harsh N.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1140-003X","authenticated-orcid":false,"given":"Elizabeth B.","family":"Habermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8084-9685","authenticated-orcid":false,"given":"Matthew C.","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommy","family":"Ivanics","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael L.","family":"Kendrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rory L.","family":"Smoot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Nagorney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitesh J.","family":"Borad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert R.","family":"McWilliams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Truty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.ijsu.2018.02.052_bib1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11938-006-0028-1","article-title":"Gallbladder cancer","volume":"9","author":"Misra","year":"2006","journal-title":"Curr. Treat. Options Gastroenterol."},{"key":"10.1016\/j.ijsu.2018.02.052_bib2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1470-2045(03)01021-0","article-title":"Carcinoma of the gallbladder","volume":"4","author":"Misra","year":"2003","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ijsu.2018.02.052_bib3","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/ijc.21683","article-title":"Gallbladder cancer worldwide: Geographical distribution and risk factors","volume":"118","author":"Randi","year":"2006","journal-title":"Int. J. Canc."},{"key":"10.1016\/j.ijsu.2018.02.052_bib4","first-page":"101","article-title":"Gallbladder cancer \u2014 a comprehensive review","volume":"6","author":"Lai","year":"2008","journal-title":"Surgery (St Louis)"},{"key":"10.1016\/j.ijsu.2018.02.052_bib5","first-page":"107","article-title":"A population-based case-control study of cancer of the bile ducts and gallbladder in Quebec, Canada","volume":"41","author":"Ghadirian","year":"1993","journal-title":"Rev. Epidemiol. Sante Publique"},{"key":"10.1016\/j.ijsu.2018.02.052_bib6","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/sj.bjc.6690101","article-title":"Gallstones, cholecystectomy and risk of cancers of the liver, biliary tract and pancreas","volume":"79","author":"Chow","year":"1999","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.ijsu.2018.02.052_bib7","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1002\/1097-0142(19951115)76:10<1747::AID-CNCR2820761011>3.0.CO;2-L","article-title":"Risk factors for gallbladder cancer. An international collaborative case-control study","volume":"76","author":"Strom","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.ijsu.2018.02.052_bib8","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S1072-7515(01)00814-6","article-title":"Surgical treatment of patients with T2 gallbladder carcinoma invading the subserosal layer","volume":"192","author":"Chijiiwa","year":"2001","journal-title":"J. Am. Coll. Surg."},{"key":"10.1016\/j.ijsu.2018.02.052_bib9","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3322\/canjclin.51.6.349","article-title":"Epidemiology and molecular pathology of gallbladder cancer","volume":"51","author":"Lazcano-Ponce","year":"2001","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.ijsu.2018.02.052_bib10","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1245\/s10434-006-9219-1","article-title":"Surgical treatment of pT2 gallbladder carcinoma: a reevaluation of the therapeutic effect of hepatectomy and extrahepatic bile duct resection based on the long-term outcome","volume":"14","author":"Yokomizo","year":"2007","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.ijsu.2018.02.052_bib11","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/j.1478-3231.2012.02792.x","article-title":"The management of hepatocellular carcinoma around the world: a comparison of guidelines from 2001 to 2011","volume":"32","author":"Song","year":"2012","journal-title":"Liver Int."},{"key":"10.1016\/j.ijsu.2018.02.052_bib12","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1634\/theoncologist.2009-0302","article-title":"Current management of gallbladder carcinoma","volume":"15","author":"Zhu","year":"2010","journal-title":"Oncol."},{"key":"10.1016\/j.ijsu.2018.02.052_bib13","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/jso.21141","article-title":"Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering cancer Centre (MSKCC)","volume":"98","author":"Duffy","year":"2008","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.ijsu.2018.02.052_bib14","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1002\/1097-0142(19920915)70:6<1498::AID-CNCR2820700609>3.0.CO;2-C","article-title":"Carcinoma of the extrahepatic bile ducts. Histologic types, stage of disease, grade, and survival rates","volume":"70","author":"Henson","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.ijsu.2018.02.052_bib15","series-title":"Trends in presentation and survival for gallbladder cancer during a period of more than 4 decades: a single-institution experience","author":"Konstantinidis","year":"2009"},{"key":"10.1016\/j.ijsu.2018.02.052_bib16","series-title":"Hepatobiliary Cancers [Internet], in NCCN Clinical Practice Guidelines in Oncology","author":"Benson","year":"2016"},{"key":"10.1016\/j.ijsu.2018.02.052_bib17","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1007\/s11605-015-2922-0","article-title":"Adjuvant therapy for gallbladder cancer: an analysis of the national cancer data Base","volume":"19","author":"Hoehn","year":"2015","journal-title":"J. Gastrointest. Surg."},{"key":"10.1016\/j.ijsu.2018.02.052_bib18","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/jso.20831","article-title":"Adjuvant radiation therapy is associated with improved survival for gallbladder carcinoma with regional metastatic disease","volume":"96","author":"Mojica","year":"2007","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.ijsu.2018.02.052_bib19","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1007\/s10620-005-3040-8","article-title":"Magnitude of combination therapy of radical resection and external beam radiotherapy for patients with carcinomas of the extrahepatic bile duct and gallbladder","volume":"50","author":"Itoh","year":"2005","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.ijsu.2018.02.052_bib21","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/0002-9610(76)90439-6","article-title":"Primary carcinoma of the gallbladder: the role of adjunctive therapy in its treatment","volume":"132","author":"Treadwell","year":"1976","journal-title":"Am. J. Surg."},{"key":"10.1016\/j.ijsu.2018.02.052_bib22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00534-007-1280-z","article-title":"Guidelines for chemotherapy of biliary tract and ampullary carcinomas","volume":"15","author":"Furuse","year":"2008","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"10.1016\/j.ijsu.2018.02.052_bib23","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/jso.21173","article-title":"Using the NCDB for cancer care improvement: an introduction to available quality assessment tools","volume":"99","author":"Raval","year":"2009","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.ijsu.2018.02.052_bib24","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1245\/s10434-007-9747-3","article-title":"The National Cancer Data Base: a powerful initiative to improve cancer care in the United States","volume":"15","author":"Bilimoria","year":"2008","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.ijsu.2018.02.052_bib25","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"Valle","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijsu.2018.02.052_bib26","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/sj.bjc.6603648","article-title":"Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials","volume":"96","author":"Eckel","year":"2007","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.ijsu.2018.02.052_bib20","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/cncr.10831","article-title":"Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma","volume":"95","author":"Takada","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.ijsu.2018.02.052_bib28","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1200\/JCO.2011.40.5381","article-title":"Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis","volume":"30","author":"Horgan","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"4 suppl","key":"10.1016\/j.ijsu.2018.02.052_bib29","article-title":"Gemox versus surveillance following surgery of localized biliary tract cancer: results of the PRODIGE 12-ACCORD 18 (UNICANCER GI) phase III trial","volume":"35","author":"Edeline","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ijsu.2018.02.052_bib30","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2009.27.15_suppl.4503","article-title":"Gemcitabine with or without cisplatin in patients (pts) with advanced or metastatic biliary tract cancer (ABC): results of a multicenter, randomized phase III trial (the UK ABC-02 trial)","author":"Valle","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ijsu.2018.02.052_bib31","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/sj.bjc.6605211","article-title":"Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study \u2013 the UK ABC-01 Study","volume":"101","author":"Valle","year":"2009","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.ijsu.2018.02.052_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijsu.2017.08.586","article-title":"The STROCSS statement: strengthening the reporting of cohort studies in surgery","author":"Agha","year":"2017","journal-title":"Int. J. Surg."},{"issue":"11","key":"10.1016\/j.ijsu.2018.02.052_bib33","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.hpb.2016.05.016","article-title":"Rates and patterns of recurrence after curative intent resection for gallbladder cancer: a multi-institution analysis from the US Extra-hepatic Biliary Malignancy Consortium","volume":"18","author":"Margonis","year":"2016","journal-title":"HPB"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743919118305831?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743919118305831?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T16:04:06Z","timestamp":1677081846000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1743919118305831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":32,"alternative-id":["S1743919118305831"],"URL":"https:\/\/doi.org\/10.1016\/j.ijsu.2018.02.052","relation":{},"ISSN":["1743-9191"],"issn-type":[{"value":"1743-9191","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adjuvant systemic therapy after resection of node positive gallbladder cancer: Time for a well-designed trial? (Results of a US-national retrospective cohort study)","name":"articletitle","label":"Article Title"},{"value":"International Journal of Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijsu.2018.02.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 IJS Publishing Group Ltd. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}